Shoosmiths acts for M Squared Lasers in health research agreement

Shoosmiths acts for M Squared Lasers in health research agreement

Published:

Author: Kellie Young

National law firm Shoosmiths has advised laser developer and manufacturer M Squared Lasers on an agreement to develop new technologies with the University of St Andrews.

Stuart Malcolm, Partner

M Squared Lasers explores, develops and manufactures next-generation lasers and photonic instruments that bring new capabilities, higher reliability and greater ease of use to a diverse range of industrial and scientific applications. The business has more than twenty years of experience in R&D and manufacturing with a track record of award-winning products.

The company recently was awarded the 2014 Sunday Times Tech Track Ones to Watch award.

The patent licence agreement covers more than 100 patents, which researchers will use to develop commercial applications for the health sector. The patents cover areas such as imaging and raman spectroscopic analysis which can be used in the fight against cancer by accurately distinguishing between normal and unhealthy cells and tissue.

Stuart Malcolm, Partner in the IPCI Team, led the negotiations with the University of St Andrews assisted by Olly Leyden, IP solicitor.

Head of the Business Innovation Unit at M Squared Lasers, Dr Nils Hemplar, said: 'I would like to thank Shoosmiths for their expert advice throughout the agreement process, which has enabled us to match our knowledge with relevant academic research to lead significant developments in healthcare. We have a longstanding relationship with Stuart and his team and their specialist approach, coupled with a very evident passion for and definitive understanding of our technology sector, ensures that we are provided with distinctive and dynamic advice, always against the backdrop of an enlightened approach, determination and absolute commitment.'

Stuart Malcolm, said: 'It was a pleasure to guide M Squared Lasers through another strategic licence arrangement in its growing IP portfolio and one that could lead to an improved understanding of life limiting illnesses and conditions such as cancer and alzheimer's disease. Our experience and expertise in intellectual property means we are well placed to help clients promote and accelerate their unique educational, research, intellectual and business assets.'

Shoosmiths' UK-wide IPCI team is one of the most comprehensive in the country with more than a dozen dedicated specialists covering healthcare, digital, music, publishing, fashion, gaming, cyber security, branding and design. The team also sits in a wider 10-office national network with the breadth to offer clients the very best advice across the business spectrum.